Breast Implants and the Risk of Lymphoma!
Recently on Jan 26th 2011, the FDA has issued a warning with regards to the possible association of a rare form of non-hodgkins’s lymphoma called anaplastic large cel lymphoma (ALCL) and women with breast implants. ALCL is not a form of breast cancer.
Although there are over 10 million women with breast implants there are fewer than 64 cases of ALCL ever reported in women with breast implants.
Because of the loose and ill-defined association between ALCL and women with breast implants, the FDA and the American Society of Plastic Surgery (ASPS) have committed to gather the appropriate data before a definitive recommendation to the public is published and final. The exact timing of such information may take a while due to the very small number of cases that are available.
The FDA continues to support the use and marketing of breast implants, saline and silicone, for the use of breast reconstruction and breast augmentation.
Women with breast implants that have no new symptoms of swelling or pain around there implants are not advised to do anything different than previously advised. Women who see changes with there breast implants feels, shape or look or start experiencing the above symptoms should check in with their physicians.
For more information please visit the FDA’s Consumer Updates page at www.FDA.gov.